Back to Grants
FEDERAL
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
This grant funds research on the synthesis and biological activity assessment of different diastereomers in the siRNA drug LEQVIO (Inclisiran).
About this program
The grant focuses on the synthesis and evaluation of various diastereomers of the siRNA drug LEQVIO (Inclisiran), which is aimed at improving its therapeutic efficacy. Researchers will investigate the biological activity of these diastereomers to determine their potential benefits in clinical applications. This research is intended for academic institutions and research organizations involved in pharmaceutical development and drug discovery.
Eligibility
Eligible entities include academic institutions and research organizations engaged in pharmaceutical research.